IceCure Medical Ltd.

Stage 4 · Declining · week 53

As of Oct 22, 2026, IceCure Medical is in Stage 4, the downtrend phase, now in week 53 (since Oct 9, 2025). It closed at $1.00, 95.9% below its 52-week high and below its 200-day average, which is falling.

$1.00

+1.85% today

$4.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ICCM early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 16w

S4 20w

S2 14w

S4 54w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 16w → S1 7w → S2 10w → S3 10w → S4 20w → S1 8w → S2 14w → S3 13w → S4 9w → S1 3w → S4 54w current

Total tracked: 165 weeks across 11 stage runs.

ICCM among Medical Devices124th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…124	ICCMIceCure Medical Ltd.	Stage 4 · wk 53	5	−46.5%

vs 52W High

-95.9%

$0.98 lo$24.18 hi

95.9% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 53

1w13w26w

Week 53, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-88.3%

200 DMA: $8.51 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.03x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-46.5%

-67.5%

-88.6%

YTD

-94.7%

-96.0%

Scan Membership

Breakout Watch

Latest: 2025-01-06

2 appearances in last 60 days. First seen: 2024-01-26.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 53 · Vol 1.03x

2026-10-21S4

Wk 52 · Vol 0.62x

2026-10-20S4

Wk 52 · Vol 0.64x

2026-10-19S4

Wk 52 · Vol 0.92x

2026-10-16S4

Wk 52 · Vol 0.65x

2026-10-15S4

Wk 52 · Vol 0.59x

2026-10-14S4

Wk 51 · Vol 0.94x

2026-10-13S4

Wk 51 · Vol 1.68x

2026-10-12S4

Wk 51 · Vol 0.51x

2026-10-09S4

Wk 51 · Vol 0.81x

2026-10-08S4

Wk 51 · Vol 2.20x

2026-10-07S4

Wk 50 · Vol 2.49x

Moving averages & range

50 DMA

$1.87

200 DMA

$8.51

52W High

$24.18

52W Low

$0.98

5D Low

$0.98

Resistance levels (recent highs)

20d High

$1.73

60d High

$3.51

120d High

$9.30

250d High

$24.15

Next resistance

+73.0%

to 20d High

ROE

-228.3%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.3

IceCure Medical: quick answers

What stage is IceCure Medical in?

As of Oct 22, 2026, IceCure Medical (ICCM) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 9, 2025 and is in week 53. What the four stages mean

Is IceCure Medical in an uptrend?

No. IceCure Medical is in a Stage 4 downtrend. It trades 88.3% below its 200-day average, which is falling.

How far is IceCure Medical from its 52-week high?

IceCure Medical closed at $1.00 on Oct 22, 2026, 95.9% below its 52-week high of $24.18. Its 52-week low is $0.98.

How has IceCure Medical performed over the past year?

As of Oct 22, 2026, IceCure Medical is down 96.0% over the past year and down 94.7% so far in 2026.

Which sector and industry is IceCure Medical in?

IceCure Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.